Insider Transactions in Q1 2025 at Rapport Therapeutics, Inc. (RAPP)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2025
|
David Bredt Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,500
-1.78%
|
$85,000
$10.85 P/Share
|
|
Mar 13
2025
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.99%
|
$900
$9.98 P/Share
|
|
Mar 12
2025
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
9,900
+50.0%
|
$99,000
$10.1 P/Share
|
|
Mar 12
2025
|
Wendy B. Young |
BUY
Open market or private purchase
|
Direct |
6,000
+50.0%
|
$60,000
$10.21 P/Share
|
|
Mar 03
2025
|
Cheryl Gault Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,987
+7.52%
|
-
|